Evidence map›Paper›PMID 30021007›Full record

ArticlePloS one2018

Rapid in vitro detection of CTX-M groups 1, 2, 8, 9 resistance genes by LAMP assays.

Odile Lalainasoa Rivoarilala, Benoît Garin, Felamboahangy Andriamahery, Jean Marc Collard

Open access · goldAbstract readValidation Study
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 30 citations in OpenAlex.

  1. Rapid commercial CTX-M diagnostics: Performance, limitations and clinical impact.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  2. Revisiting the Metallo-International journal of microbiology · 2025
    Review
  3. Article
  4. Diverse Role ofAntibiotics (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Prevalence of Extended-SpectrumAnimals : an open access journal from MDPI · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Odile Lalainasoa RivoarilalaUnité Bactériologie Expérimentale, Institut Pasteur de Madagascar, Madagascar.ORCID 0000-0002-4899-1996
Benoît GarinUnité Bactériologie Expérimentale, Institut Pasteur de Madagascar, Madagascar.
Felamboahangy AndriamaheryUnité Bactériologie Expérimentale, Institut Pasteur de Madagascar, Madagascar.
Jean Marc CollardUnité Bactériologie Expérimentale, Institut Pasteur de Madagascar, Madagascar.
Institut Pasteur de Madagascar · MGUniversity of Antananarivo · MG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of bacteria producing CTX-M Extended-Spectrum β-lactamases (ESBLs) has increased around the world and some of them became a major cause of infections such as bloodstream or urinary tract infections (UTI). We developed a loop-mediated isothermal amplification (LAMP) assay for a simple, rapid and sensitive detection of the four most common CTX-M groups, namely CTX-M groups 1, 2, 8 and 9.

methodsLAMP primers targeting the four ESBLs CTX-M groups were designed using the Primer Explorer V4 software. The detection limit of the method was tested by serial dilution of reference DNAs. The primer specificity of the LAMP reaction was tested on DNA extracted from six strains producing various group of CTX-M and validated using DNA extracted from CTX-M-resistant clinical isolates (isolated from pus, urine, or blood). Results were compared with those of conventional PCR.

resultsWe were able to detect down to 0.1 pg/ul of DNA using the newly developed LAMP assays whereas the minimal amount detectable for conventional PCR was 50 to 100pg/ul, indicating that the LAMP assay was found to have a detection limit at least 500 to 1000 times lower than the PCR. Additionally, representative genes from the CTX-M groups 1, 2, 8 and 9 were amplified using the designed assay and no cross amplification was observed between the four CTX-M groups, demonstrating the specificity of the LAMP assay. Of the 37 clinical strains tested, the four LAMP assays showed 100% sensitivity and 87%, 97%, 100%, 100% specificity for the CTX-M groups 1, 2, 8 and 9 respectively.

conclusionBeing sensitive, specific, rapid and standard methods, the LAMP assays developed in this study have a potential to be beneficial tools in molecular epidemiology and surveillance studies of the four prevalent EBSLs CTX-M groups even in low cost laboratory.

Indexed as

Nucleic Acid Amplification TechniquesBacterial Proteinsbeta-LactamasesEnterobacteriaceae InfectionsEscherichia coliHumansSalmonellaSensitivity and SpecificityTime FactorsBacterial Proteinsbeta-Lactamases

Identifiers

PMID30021007
PMCPMC6051616
OpenAlexW2884948716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.